Literature DB >> 11564508

Oesophageal motility disorders.

J E Richter1.   

Abstract

Oesophageal motility disorders comprise various abnormal manometric patterns which usually present with dysphagia or chest pain. Some, such as achalasia, are diseases with a well defined pathology, characteristic manometric features, and good response to treatments directed at the pathophysiological abnormalities. Other disorders, such as diffuse oesophageal spasm and hypercontracting oesophagus, have no well defined pathology and could represent a range of motility changes associated with subtle neuropathic changes, gastro-oesophageal reflux, and anxiety states. Although manometric patterns have been defined for these disorders, the relation with symptoms is poorly defined and the response to medical or surgical therapy unpredictable. Hypocontracting oesophagus is generally caused by weak musculature commonly associated with gastro-oesophageal reflux disease. Secondary oesophageal motility disorders can be caused by collagen vascular diseases, diabetes, Chagas' disease, amyloidosis, alcoholism, myxo-oedema, multiple sclerosis, idiopathic pseudo-obstruction, or the ageing process.

Entities:  

Mesh:

Year:  2001        PMID: 11564508     DOI: 10.1016/S0140-6736(01)05973-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  67 in total

1.  Patients with esophageal motility disorders show distinct patterns based on axial force measurements.

Authors:  F H Lundager; J Tack; K Blondeau; A M Drewes; H Gregersen
Journal:  Dig Dis Sci       Date:  2012-06-06       Impact factor: 3.199

2.  Relationship between manometric findings and reported symptoms in nutcracker esophagus: insights gained from a review of 313 patients.

Authors:  Kazuto Tsuboi; Sumeet K Mittal; András Legner; Fumiaki Yano; Charles J Filipi
Journal:  J Gastroenterol       Date:  2010-06-09       Impact factor: 7.527

3.  Systematic review and meta-analysis: Efficacy and safety of POEM for achalasia.

Authors:  Lavinia A Barbieri; Cesare Hassan; Riccardo Rosati; Uberto Fumagalli Romario; Loredana Correale; Alessandro Repici
Journal:  United European Gastroenterol J       Date:  2015-08       Impact factor: 4.623

4.  Successful use of phosphodiesterase type 5 inhibitors to control symptomatic esophageal hypercontractility: a case report.

Authors:  Amit Agrawal; Radu Tutuian; Amine Hila; Donald O Castell
Journal:  Dig Dis Sci       Date:  2005-11       Impact factor: 3.199

5.  Clinical, radiographic, and manometric evolution of esophageal involvement by Chagas' disease.

Authors:  Ulysses G Meneghelli; Fernanda M Peria; Fabiana M R Darezzo; Fernando H Almeida; Carla M Rodrigues; Lilian R O Aprile; Roberto O Dantas
Journal:  Dysphagia       Date:  2005       Impact factor: 3.438

6.  Initial experience with magnetic resonance fluoroscopy in the evaluation of oesophageal motility disorders. Comparison with manometry and barium fluoroscopy.

Authors:  Valeria Panebianco; Fortunee Irene Habib; Ernesto Tomei; Pasquale Paolantonio; Michele Anzidei; Andrea Laghi; Carlo Catalano; Roberto Passariello
Journal:  Eur Radiol       Date:  2006-04-26       Impact factor: 5.315

Review 7.  Technological insights: combined impedance manometry for esophageal motility testing-current results and further implications.

Authors:  Huan Nam Nguyen; Gerson Ricardo Souza Domingues; Frank Lammert
Journal:  World J Gastroenterol       Date:  2006-10-21       Impact factor: 5.742

8.  A patient with dysphagia.

Authors:  J Y Kang
Journal:  Gut       Date:  2007-10       Impact factor: 23.059

9.  Epidemiological analysis of achalasia in Japan using a large-scale claims database.

Authors:  Hiroki Sato; Hiroshi Yokomichi; Kazuya Takahashi; Kentaro Tominaga; Takeshi Mizusawa; Naruhiro Kimura; Yuzo Kawata; Shuji Terai
Journal:  J Gastroenterol       Date:  2019-01-03       Impact factor: 7.527

Review 10.  Surgical treatment of primary esophageal motility disorders.

Authors:  Fernando A Herbella; Ana C Tineli; Jorge L Wilson; Jose C Del Grande
Journal:  J Gastrointest Surg       Date:  2007-11-13       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.